Chemical composition and antifungal potential of Brazilian propolis against Candida spp.

Journal de Mycologie Medicale

Volumn 26, Issue 2, 2016, Pages 122-132

  Freires, I A ^a   Queiroz, V C P P ^a   Furletti, V F ^a   Ikegaki, M ^b   de Alencar, S M ^c   Duarte, M C T ^a   Rosalen, P L ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biofilms; Candida; Candidiasis; Isoflavonoids; Propolis

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; CAFFEIC ACID PHENETHYL ESTER; DICHLOROMETHANE; FORMONONETIN; HEXANE; ISOFLAVONOID; KAEMPFEROL; MEDICARPIN; NYSTATIN; PARA COUMARIC ACID; PHENOL; PROPOLIS; QUERCETIN; TRITERPENE; UNCLASSIFIED DRUG; VESTITOL; WATER; ANTIFUNGAL AGENT;

ANTIFUNGAL ACTIVITY; APIS MELLIFERA; ARTICLE; BIOFILM; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL DAMAGE; CONTROLLED STUDY; DRUG IDENTIFICATION; FUNGAL STRAIN; MASS FRAGMENTOGRAPHY; MINIMUM FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYTOCHEMISTRY; PICHIA KUDRIAVZEVII; SCANNING ELECTRON MICROSCOPY; CANDIDIASIS; CHEMISTRY; DRUG EFFECTS; FRACTIONATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDIASIS; CHEMICAL FRACTIONATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MICROBIAL SENSITIVITY TESTS; PROPOLIS;

EID: 84964344226     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2016.01.003     Document Type: Article

References (39)

1. Alencar S.M., Cadorin T.L., Castro M.L., Ribeiro I.S., Costa Neto C.M., Cury J.A., et al. Chemical composition and biological activity of a new type of Brazilian propolis: red propolis. J Ethnopharmacol 2007, 113:278-283.
2. Báidez A.G., Gómez P., Del Río J.A., Ortuño A. Antifungal capacity of major phenolic compounds of Olea europaea L. against Phytophthora megasperma Drechsler and Cylindrocarpon destructans (Zinssm.) Scholten. Physiol Mol Plant Pathol 2006, 69:224-229.
3. Bankova V. Chemical diversity of propolis and the problem of standardization. J Ethnopharmacol 2005, 100:114-117.
4. Banskota A.H., Tezuka Y., Kadota S. Recent progress in pharmacological research of propolis. Phytother Res 2001, 15:561-571.
5. Bueno-Silva B., Alencar S.M., Koo H., Ikegaki M., Silva G.V.J., Napimoga M.H. Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis. J Agric Food Chem 2013, 61:4546-4550.
6. Bueno-Silva B., Koo H., Falsetta M.L., Alencar S.M., Ikegaki M., Rosalen P.L. Effect of neovestitol-vestitol containing Brazilian red propolis on accumulation of biofilm in vitro and development of dental caries in vivo. Biofouling 2013, 29:1233-1242.
7. Cabral I.S.R., Oldoni T.L.C., Alencar S.M., Rosalen P.L., Ikegaki M. The correlation between the phenolic composition and biological activities of two varieties of Brazilian propolis (G6 and G12). Braz J Pharm Sci 2012, 48:557-564.
8. Capoci I.R.G., Bonfim-Mendonça P.S., Arita G.S., Pereira R.R.A., Consolaro M.E.L., Bruschi M.L., et al. Propolis is an efficient fungicide and inhibitor of biofilm production by vaginal Candida albicans. Evid Based Complement Altern Med 2015, 2015:287693. 10.1155/2015/287693.
9. Castro M.L., Cury J.A., Rosalen P.L., Alencar S.M., Ikegaki M., Duarte S., et al. Propolis from southeastern and northeastern of Brazil: the influence of seasonality in antibacterial activity and phenolic composition. Quimica Nova 2007, 30:1512-1516.
10. Clinical Laboratory Standards Institute (CLSI) Protocol M27-A3 reference method for broth dilution antifungal susceptibility testing of yeasts 2008, CLSI, Pennsylvania. 3rd ed.
11. Cushnie T.P.T., Lamb A.J. Antimicrobial activity of flavonoids. Int J Antimicrob Agents 2005, 26:343-356.
12. Dababneh L., Shomali W., Raad I.I. Vascular catheter-related infections. Infections in hematology 2015, 187-195. Springer, Berlin, Heidelberg. 10.1007/978-3-662-44000-1_11. G. Maschmeyer, K.V.I. Rolston (Eds.).
13. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 2003, 11:30-36.
14. Duarte S., Koo H., Bowen W.H., Hayacibara M.F., Cury J.A., Ikegaki M., et al. Effect of a novel type of propolis and its chemical fractions on glucosyltransferases and on growth and adherence of mutans streptococci. Biol Pharm Bull 2003, 26:527-531.
15. Duarte S., Rosalen P.L., Hayacibara M.F., Cury J.A., Bowen W.H., Marquis R.E., et al. The influence of a novel propolis on mutans streptococci biofilms and caries development in rats. Arch Oral Biol 2006, 51:15-22.
16. Fernández-Ruiz M., Puig-Asensio M., Guinea J., Almirante B., Padilla B., Almela M., et al. Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance. J Infect 2015, 71:385-394.
17. Freires I.A., Denny C., Benso B., Alencar S.M., Rosalen P.L. Antibacterial activity of essential oils and their isolated constituents against cariogenic bacteria: a systematic review. Molecules 2015, 20:7329-7358.
18. Freires I.A., Murata R.M., Furletti V.F., Sartoratto A., Alencar S.M., Figueira G.M., et al. Coriandrum sativum L. (coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expression. PLoS One 2014, 9:e99086. 10.1371/journal.pone.0099086.
19. Hayacibara M.F., Koo H., Rosalen P.L., Duarte S., Franco E.M., Bowen W.H., et al. In vitro and in vivo effects of isolated fractions of Brazilian propolis on caries development. J Ethnopharmacol 2005, 101:110-115.
20. Jeon J.G., Rosalen P.L., Falsetta M.L., Koo H. Natural products in caries research: current (limited) knowledge, challenges and future perspective. Caries Res 2011, 45:243-263.
21. Jiménez-González L., Álvarez-Corral M., Muñoz-Dorado M., Rodríguez-García I. Pterocarpans: interesting natural products with antifungal activity and other biological properties. Phytochem Rev 2008, 7:125-154.
22. Koo H., Pearson S.K., Scott-Anne K., Abranches J., Cury J.A., Rosalen P.L., et al. Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in rats. Oral Microbiol Immunol 2002, 17:337-343.
23. Koo H., Rosalen P.L., Cury J.A., Ambrosano G.M., Murata R.M., Yatsuda R., et al. Effect of a new variety of Apis mellifera propolis on mutans Streptococci. Curr Microbiol 2000, 41:192-196.
24. Lewis R.E. Current concepts in antifungal pharmacology. Mayo Clin Proc 2011, 86:805-817.
25. López B.G.C., Schmidt E.M., Eberlin M.N., Sawaya A.C.H.F. Phytochemical markers of different types of red propolis. Food Chem 2014, 146:174-180.
26. Lotti C., Castro G.M.M., Sá L.F.R., Silva B.A.F.S., Tessis A.C., Piccinelli A.L., et al. Inhibition of Saccharomyces cerevisiae Pdr5p by a natural compound extracted from Brazilian Red Propolis. Braz J Pharmacogn 2011, 21:901-907.
27. Mello A.M., Gomes R.T., Lara S.R., Silva L.G., Alves J.B., Cortés M.E., et al. The effect of Brazilian propolis on the germ tube formation and cell wall of Candida albicans. Pharmacol Online 2006, 3:352-358. [Available from: http://pharmacologyonline.silae.it/files/archives/2006/vol3/029.Mello.pdf].
28. Park Y.K., Alencar S.M., Aguiar C.L. Botanical origin and chemical composition of Brazilian propolis. J Agric Food Chem 2002, 50:2502-2506.
29. Pippi B., Lana A.J.D., Moraes R.C., Güez C.M., Machado M., Oliveira L.F.S., et al. In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp. J Appl Microbiol 2015, 118:839-850.
30. Schmidt E.M., Stock D., Chada F.J.G., Finger D., Sawaya A.C.H.F., Eberlin M.N., et al. A comparison between characterization and biological properties of Brazilian fresh and aged propolis. Bio Med Res Int 2014, 257617. 10.1155/2014/257617.
31. Siddiqui Z.N., Farooq F., Musthafa T.N.M., Ahmad A., Khan A.U. Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives. J Saudi Chem Soc 2013, 17:237-243.
32. Silici S., Koç N.A., Ayangil D., Çankaya S. Antifungal activities of propolis collected by different races of honeybees against yeasts isolated from patients with superficial mycoses. J Pharmacol Sci 2005, 99:39-44.
33. Silva B.B., Rosalen P.L., Cury J.A., Ikegaki M., Souza V.C., Esteves A., et al. Chemical composition and botanical origin of red propolis, a new type of Brazilian propolis. Evid Based Complement Altern Med 2008, 5:313-316.
34. Siqueira A.B.S., Gomes B.S., Cambuim I., Maia R., Abreu S., Souza-Motta C.M., et al. Trichophyton species susceptibility to green and red propolis from Brazil. Letters Appl Microbiol 2009, 48:90-96.
35. Sohaimy S.A.E., Masry S.H.D. Phenolic content, antioxidant and antimicrobial activities of Egyptian and Chinese propolis. Am Eurasian J Agric Environ Sci 2014, 14:1116-1124.
36. Suleman T., Vuuren S.V., Sandasi M., Viljoen A.M. Antimicrobial activity and chemometric modelling of South African propolis. J Appl Microbiol 2015, 119:981-990.
37. Trusheva B., Popova M., Bankova V., Simova S., Marcucci M.C., Miorin P.L. Bioactive constituents of Brazilian red propolis. Evid Based Complement Altern Med 2006, 3:249-254.
38. Wagh V.D. Propolis: a wonder bees product and its pharmacological potentials. Adv Pharm Sci 2013, 2013:308249. [11 p.]. 10.1155/2013/308249.
39. Zotchev S.B. Polyene macrolide antibiotics and their applications in human therapy. Curr Med Chem 2003, 10:211-223.